; and ; and (C) by adding at the end the following: (6) providing regulatory consultation to device sponsors in support of the submission of an application for a pediatric device, where appropriate. ; and (2) in subsection (e), by striking 2017 and inserting 2022 . 5. Meeting on pediatric device development (a) In general Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall convene a public meeting regarding opportunities and barriers to the development, approval, and labeling of pediatric medical devices. Such meeting shall include representatives from the medical device industry, academia, recipients of funding under section 305 of the Pediatric Medical Device Safety and Improvement Act of 2007 ( Public Law 110–85 ; 42 U.S.C. 282 note), medical provider organizations, and organizations representing patients and consumers. (b) Topics The meeting described in subsection (a) shall include consideration of ways to— (1) improve research infrastructure and research networks to facilitate the conduct of clinical studies of devices for children that would result in the approval and labeling of medical devices for children; (2) appropriately use extrapolation under section 515A(b) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360e–1(b) ); (3) enhance the appropriate use of postmarket registries and data to increase pediatric medical device labeling; (4) increase Food and Drug Administration assistance to medical device manufacturers in developing devices for children that are approved and labeled for their use